Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Cytokine. 2015 Feb 14;73(1):8–15. doi: 10.1016/j.cyto.2015.01.017

Fig. 5.

Fig. 5

Effect of an inhibitor of M2b monocytes on the impaired antibacterial resistance of the chimeras inoculated with ORM1-monocytes or treated with ORM1. The chimeras inoculated with ORM1-monocytes or treated with ORM1 (see Fig. 5 experiments) were i.v. treated with 6 mg/chimera of CCL1 antisense ODN or scrambled ODN (control) twice a day for 2 days beginning 2 h after WBC inoculation. Then, these chimeras were i.v. infected with 2 × 105 CFU/chimera of MRSA. Three days after infection, the growth of bacteria in various organs of these chimeras were determined by a colony-counting method. Data are displayed by the mean ± SEM from 3 or 4 chimeras per group. Data are representative of at least two independent experiments. * P < 0.05, ** P < 0.01.